XSTO
SPEC
Market cap992kUSD
Oct 07, Last price
0.02SEK
1D
-2.26%
1Q
-65.47%
Jan 2017
-98.99%
IPO
-98.81%
Name
SpectraCure AB (publ)
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
34.69%
Rev. gr., 5y
661.46%
Revenues
0
Net income
-56m
L+143.78%
CFO
-24m
L+10.08%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Spectaire Holdings Inc. specializes in developing solutions for the measurement, oversight, and reduction of greenhouse gases, including carbon dioxide equivalents. A key component of their product line is AireCore, an advanced micro-mass-spectrometer designed to provide continuous monitoring and tracking, assisting clients in achieving their emissions targets. The company, headquartered in Watertown, Massachusetts, caters to a diverse array of sectors, including logistics, energy, agriculture, academic institutions, and indoor air quality management.
Key people
Jorgen Wennberg
Independent Chairman of the Board · since 2022
Chief Financial Officer · since 2018
Johannes Swartling
Chief Executive Officer · since 2025
Marcelo Thompson
Chief Technology Officer · since 2025
Annika Andersson
Public Relations Manager · since 2019
Johan Glindre
Head of Clinical Affairs · since 2021
Johan Ingemansson
Head of Business Development · since 2021
Masoud Khayyami
Director · since 2021
Stefan Andersson-Engels
Independent Director · since 2025
Jesper Freij
Independent Director · since 2022
Tomas Kramar
Independent Director · since 2022
Patrik Ringblom
Independent Director · since 2025
Headquarters & legal address
GASVERKSGATAN, 1
Lund, M 222 29
SE
Lund, M 222 29
SE
Previous name
SpectraCure AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||